Quartel Adrian W
Chief Medical Officer
Quartel Adrian W has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Feb 2, 2026.
On the most recent filing, Quartel Adrian W is listed as Chief Medical Officer at ZEVRA THERAPEUTICS, INC. Inside the rolling window, Quartel Adrian W reported no open-market purchases and 1 open-market sale totaling $40K in ZVRA.
Companies traded
Other insiders at ZVRA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$40K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Quartel Adrian W made?
Quartel Adrian W has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Quartel Adrian W trade?
Quartel Adrian W has filed SEC Form 4 disclosures for 1 company, including ZVRA.
When was Quartel Adrian W's most recent SEC Form 4 filing?
Quartel Adrian W's most recent SEC Form 4 filing on Tracefour is dated Feb 2, 2026.
What is Quartel Adrian W's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Quartel Adrian W is listed as Chief Medical Officer.
What is Quartel Adrian W's total buy and sell value in the current window?
Inside the rolling retention window, Quartel Adrian W bought $0 and sold $40K based on SEC Form 4 filings.
What was Quartel Adrian W's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,533 ZVRA shares on 2026-01-30, worth $40K, per SEC Form 4 filings.